Christopher Andrews, MD, MSc, FRCPC, a gastroenterologist with the University of Calgary in Canada, has joined the M Pharmaceutical board of directors.
M Pharmaceutical is focused on developing biomedical technologies for obesity and diabetes.
Dr. Andrews focuses on stomach disorders and physiology. He completed advanced training in GI motility and function, as well as a master's degree in clinical health research, at Mayo Clinic in Rochester, Minn.